Our Viral Antigens portfolio includes a broad selection of native antigens derived from broth cultures as well as high-quality recombinant antigens for research, diagnostic, and assay development applications. The portfolio is designed to provide reliable performance, high consistency, and flexibility across a wide range of workflows.
We offer carefully selected antigen formats to support diverse application requirements, combining quality manufacturing with dependable batch-to-batch reproducibility.
